Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesImexhs Ltd

Imexhs Ltd

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
0.33 AUD -0.01 ( 4.35%)
Last update at 2026-11-12T04:03:00Z
VOLUME
1579
Market Cap
18.77M

Momentum Score

…

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists' interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.33
Low
0.33
High
52 Week Price Range
0.25
Low
0.47
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Imexhs Ltd (IME.AU) is an Australian-listed company for which publicly available disclosures are limited, so its core operations are not well documented in accessible sources. Long-term growth drivers may include successful execution of any management strategy, expansion of revenue-generating activities, and improved access to capital markets, which could support scale and profitability if realized.
Material risks include limited disclosure and transparency, low liquidity and small-cap volatility on the ASX, execution and financing risk, and potential regulatory or operational uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.34
Dividend Yield
-
Revenue TTM
31.27M
Revenue Per Share
0.58
Gross Profit TTM
14.97M
Debt / Equity
0.04
ROE
1.19%
Net Debt
-2.73M
ROCE
-4.37%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.04M -2.57M -4.28M -2.95M -4.56M
Net income -2.88M -2.62M -4.19M -3.04M -4.70M
Selling general administrative - 7.46M 5.54M 5.61M 6.09M
Selling and marketing expenses - 0.04M 0.11M 0.15M 0.14M
Gross profit 8.31M 11.03M 3.50M 17.12M 13.37M
Reconciled depreciation - 2.15M 2.43M 1.76M 1.24M
Ebit -0.70M -2.11M -3.69M -2.50M -4.23M
Ebitda 1.52M 0.05M -1.26M -0.74M -2.99M
Depreciation and amortization 2.22M 2.15M 2.43M 1.76M 1.24M
Operating income -0.70M -0.37M -2.70M -2.50M -4.23M
Other operating expenses 29.67M 26.90M 22.26M 19.66M 17.46M
Interest expense 0.38M 0.47M 0.33M 0.44M 0.31M
Tax provision - 0.06M 0.17M 0.09M 0.14M
Interest income - 0.03M 0.03M 0.05M 0.65M
Net interest income - -0.44M -0.30M -0.40M -0.29M
Income tax expense -0.16M 0.06M 0.17M 0.09M 0.14M
Total revenue 28.97M 26.57M 19.67M 17.12M 13.37M
Total operating expenses 9.01M 11.36M 8.55M 19.66M 17.46M
Cost of revenue 20.66M 15.54M 16.17M 11.66M 9.29M
Total other income expense net -2.34M -2.20M -1.58M -0.44M -0.32M
Net income from continuing ops - -2.63M -4.19M -3.04M -4.70M
Net income applicable to common shares - -2.63M -4.45M -3.04M -4.70M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 23.73M 21.81M 22.65M 20.99M 25.76M
Intangible assets 3.30M 3.52M - 3.26M 3.01M
Other current assets 0.65M 0.97M 0.27M 0.85M 0.26M
Total liab 7.86M 7.33M 6.67M 5.09M 9.11M
Total stockholder equity 15.87M 14.47M 15.98M 15.90M 16.65M
Other current liab 2.46M 2.94M 2.78M 1.88M 0.33M
Common stock 42.89M 40.29M 38.66M 38.48M 34.77M
Capital stock - - - 38.48M 34.77M
Retained earnings -33.21M -30.33M -27.44M -23.25M -20.21M
Other liab - - - 0.06M 0.72M
Good will 3.35M 4.61M 4.80M 4.86M 5.32M
Other assets - - - 0.63M 1.40M
Cash 3.30M 2.07M 2.36M 1.91M 4.19M
Cash and equivalents - - - - 4.19M
Total current liabilities 7.76M 6.89M 6.37M 4.48M 7.10M
Current deferred revenue 1.20M - 0.06M - 2.47M
Net debt -2.73M -0.88M -1.07M -0.79M -1.79M
Short term debt 0.55M 0.82M 1.08M 0.57M 1.11M
Short long term debt - - - 0.55M 1.08M
Short long term debt total 0.57M 1.19M 1.29M 1.12M 2.40M
Other stockholder equity - - 0.00M -3.29M 2.10M
Property plant equipment - - - 3.73M 4.50M
Total current assets 13.44M 9.26M 8.92M 8.51M 11.54M
Net tangible assets - - - 7.78M 8.32M
Net receivables 9.34M 5.89M 6.18M 5.37M 7.01M
Long term debt - - - 0.54M 1.29M
Inventory 0.15M 0.33M 0.11M 0.10M 0.08M
Accounts payable 3.55M 3.12M 2.45M 2.03M 3.19M
Accumulated other comprehensive income 6.19M 4.51M 4.77M 0.68M 2.10M
Non currrent assets other - 1.13M 3.78M 0.63M 1.40M
Non current assets total 10.29M 12.55M 13.74M 12.48M 14.22M
Capital lease obligations - - - 0.03M 0.03M
Long term debt total - - - 0.54M 1.29M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.77M -2.13M -2.22M -3.39M
Change to liabilities - - - -1.21M -2.29M
Total cashflows from investing activities -1.19M -0.77M -2.13M -2.22M -3.39M
Net borrowings - -0.11M -0.04M -1.36M -1.10M
Total cash from financing activities 1.68M 1.18M -0.10M 2.25M -0.16M
Change to operating activities - - - -0.32M 0.30M
Net income -2.88M -2.63M -4.19M -3.04M -4.70M
Change in cash 1.23M -0.29M 0.45M -2.27M -6.61M
Begin period cash flow 2.07M 2.36M 1.91M 4.19M 10.80M
End period cash flow 3.30M 2.07M 2.36M 1.91M 4.19M
Total cash from operating activities 0.56M -0.63M 2.61M -1.28M -2.97M
Issuance of capital stock - 1.50M - 3.98M 0.97M
Depreciation 2.22M 2.15M 2.43M 1.76M 1.24M
Other cashflows from investing activities - 0.32M -0.90M -0.19M -0.82M
Dividends paid - - - - -0.51M
Change to inventory 0.18M -0.22M -0.01M -0.02M 0.29M
Change to account receivables -2.74M -1.54M 0.04M 0.60M 1.33M
Sale purchase of stock - -0.12M -0.01M -0.36M -0.03M
Other cashflows from financing activities -0.09M 1.38M -0.05M -0.08M 0.93M
Change to netincome - - - 0.03M 0.85M
Capital expenditures 0.32M 1.06M 2.20M 2.03M 2.56M
Change in working capital -1.39M -1.82M 1.81M -1.62M -0.70M
Stock based compensation - 0.36M 0.59M - -
Other non cash items 2.62M 1.30M 3.15M 1.28M 3.46M
Free cash flow 0.24M -1.69M 0.41M -3.31M -5.53M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
IME
Imexhs Ltd		 -0.01
4.35%		 0.33 - - 0.60 1.07 0.54 7.10
SHL
Sonic Healthcare Ltd		 0.09
0.45%		 19.92 16.16 17.21 0.90 1.15 1.36 8.10
IDX
Integral Diagnostics Ltd		 -
-%		 1.70 28.83 15.24 0.82 0.97 1.52 9.49
ACL
Australian Clinical Labs Ltd		 0.01
0.30%		 3.33 26.67 16.84 0.81 3.95 1.24 5.12
HLS
Healius Ltd		 0.01
2.86%		 0.54 - 29.24 0.26 2.08 0.94 10.14

Profile*

Imexhs Ltd

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists' interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.

32 Martin Place, Sydney, NSW, Australia, 2020

61 2 9030 0040

https://www.imexhs.com

290

Name Title Year Born
Dr. German Arango Co-Founder, CEO & Director NA
Ms. Reena Minhas CFO & Company Sec. NA
Dr. Jorge Marin Co-Founder & Chief Medical Officer NA
Mr. Andres Vanegas Co-Founder & Strategic Accounts Mang. NA
Mr. Alexander Sanz Co-Founder & CTO NA
Mr. Alejandro Varettoni Chief Sales Officer NA
Dr. German Arango Co-Founder, CEO, MD & Director NA
Ms. Reena Minhas CFO & Company Secretary NA
Dr. German Arango Co-Founder, CEO, MD & Director NA
Ms. Reena Minhas CFO & Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…